WallStSmart

Braskem SA Class A (BAK)vsDow Inc (DOW)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 71% more annual revenue ($70.60B vs $41.32B). DOW leads profitability with a -3.1% profit margin vs -7.8%. BAK appears more attractively valued with a PEG of 1.46. BAK earns a higher WallStSmart Score of 52/100 (C-).

BAK

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

DOW

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 3.5Value: 3.0Quality: 6.0
Piotroski: 2/9Altman Z: 1.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

DOWSignificantly Overvalued (-17.9%)

Margin of Safety

-17.9%

Fair Value

$28.85

Current Price

$28.02

$0.83 premium

UndervaluedFair: $28.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

DOW2 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
19.7%8/10

19.7% revenue growth

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$377.34M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

DOW4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
38.892/10

Expensive relative to growth rate

Return on EquityProfitability
-4.9%2/10

ROE of -4.9% — below average capital efficiency

EPS GrowthGrowth
-73.3%2/10

Earnings declined 73.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : DOW

The strongest argument for DOW centers on Price/Book, Revenue Growth. Revenue growth of 19.7% demonstrates continued momentum.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : DOW

The primary concerns for DOW are Piotroski F-Score, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

BAK carries more volatility with a beta of 0.68 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

DOW generates stronger free cash flow (699M), providing more financial flexibility.

Monitor CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BAK scores higher overall (52/100 vs 49/100) and 21.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Dow Inc

BASIC MATERIALS · CHEMICALS · USA

Dow Inc. is an American commodity chemical company. The company is headquartered in Midland, Michigan.

Visit Website →

Want to dig deeper into these stocks?